Tech Company Financing Transactions
Enginprime Medical Funding Round
Qiming Ventures and private investors joined a $12 million Series A funding round for Enginprime Medical. The round was announced on 8/18/2026.
Transaction Overview
Company Name
Announced On
8/18/2026
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Qiming Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the capital to fund the registration clinical trial of OpusOne in China and support regulatory submissions and clinical development of its platform globally.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Hangzhou, Undisclosed
China
Hangzhou, Undisclosed
China
Phone
Undisclosed
Email Address
Not Recorded
Overview
Enginprime Medical is a Shanghai and Hangzhou-based medical device startup founded in 2023 that specializes in developing next-generation percutaneous ventricular assist devices (pVAD), commonly known as heart pumps.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zhiyong Liu
Browse more venture capital transactions:
Prev: 8/18/2026: Grounded venture capital transaction
Next: 8/18/2026: DefendEye venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document funding rounds that are announced publicly. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs